Other Assets, Noncurrent in USD of ImmunityBio, Inc. from Q4 2014 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
ImmunityBio, Inc. quarterly Other Assets, Noncurrent history and change rate from Q4 2014 to Q4 2024.
  • ImmunityBio, Inc. Other Assets, Noncurrent for the quarter ending 31 Dec 2024 was $4.83M, a 67.6% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

ImmunityBio, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $4.83M +$1.95M +67.6% 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 $3.64M +$216K +6.3% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $2.66M -$1.11M -29.5% 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $2.73M -$1.82M -40% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $2.88M -$1.98M -40.7% 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 $3.43M -$1.71M -33.2% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $3.77M -$2.25M -37.4% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $4.55M -$1.93M -29.8% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $4.86M -$1.92M -28.3% 31 Dec 2022 10-K 19 Mar 2024
Q3 2022 $5.13M -$2.31M -31% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $6.02M -$773K -11.4% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 $6.48M +$4.57M +240% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $6.78M +$4.18M +161% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 $7.44M +$5.41M +267% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $6.8M +$4.2M +161% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $1.91M -$2.15M -53% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 $2.6M -$2.92M -52.9% 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 $2.03M -$1.26M -38.2% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $2.6M +$2.29M +739% 30 Jun 2020 10-Q 07 Aug 2020
Q1 2020 $4.05M +$3.74M +1190% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $5.52M +$3.99M +261% 31 Dec 2019 8-K/A 22 Apr 2021
Q3 2019 $3.28M +$1.7M +107% 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 $310K -$44K -12.4% 30 Jun 2019 10-Q 06 Aug 2019
Q1 2019 $314K -$52K -14.2% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $1.53M +$1.2M +363% 31 Dec 2018 10-K 25 Mar 2020
Q3 2018 $1.58M +$1.26M +389% 30 Sep 2018 10-Q 07 Nov 2018
Q2 2018 $354K +$19K +5.67% 30 Jun 2018 10-Q 06 Aug 2018
Q1 2018 $366K -$295K -44.6% 31 Mar 2018 10-Q 07 May 2018
Q4 2017 $330K -$458K -58.1% 31 Dec 2017 10-K 13 Mar 2019
Q3 2017 $324K -$538K -62.4% 30 Sep 2017 10-Q 07 Nov 2017
Q2 2017 $335K -$805K -70.6% 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 $661K -$1.04M -61% 31 Mar 2017 10-Q 08 May 2017
Q4 2016 $788K -$571K -42% 31 Dec 2016 10-K 12 Mar 2018
Q3 2016 $862K -$464K -35% 30 Sep 2016 10-Q 10 Nov 2016
Q2 2016 $1.14M -$2.62M -69.7% 30 Jun 2016 10-Q 15 Aug 2016
Q1 2016 $1.7M 31 Mar 2016 10-Q 16 May 2016
Q4 2015 $1.36M +$950K +232% 31 Dec 2015 10-K 15 Mar 2017
Q3 2015 $1.33M 30 Sep 2015 10-Q 12 Nov 2015
Q2 2015 $3.76M 30 Jun 2015 10-Q 10 Sep 2015
Q4 2014 $409K 31 Dec 2014 10-K 30 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.